Vertex Pharmaceuticals
VRTX
VRTX
1,661 hedge funds and large institutions have $107B invested in Vertex Pharmaceuticals in 2025 Q4 according to their latest regulatory filings, with 269 funds opening new positions, 616 increasing their positions, 566 reducing their positions, and 98 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
10% more funds holding
Funds holding: 1,516 → 1,661 (+145)
2.45% more ownership
Funds ownership: 90.54% → 92.99% (+2.4%)
9% more repeat investments, than reductions
Existing positions increased: 616 | Existing positions reduced: 566
Holders
1,661
Holding in Top 10
15
Calls
$877M
Puts
$649M
Top Buyers
| 1 | +$646M | |
| 2 | +$478M | |
| 3 | +$383M | |
| 4 |
Capital Research Global Investors
Los Angeles,
California
|
+$329M |
| 5 |
American Century Companies
Kansas City,
Missouri
|
+$172M |
Top Sellers
| 1 | -$646M | |
| 2 | -$470M | |
| 3 | -$410M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$330M |
| 5 |
DZ Bank
Frankfurt Am Main,
Germany
|
-$232M |